SCHEMBL6517660

SCHEMBL6517660

COc1ccc2cc(C(=O)NCCCCCC(=O)NNC(=O)[C@@H](N)CC(C)C)c(=O)oc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B10 O60218 1/20 0.52
▸ AKR1B1 P15121 1/20 0.52
▸ NPC1 O15118 2/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ ALDH1A1 P00352 5/20 0.50
▸ HPGD P15428 5/20 0.50
▸ KDM4E B2RXH2 4/20 0.50
▸ CA12 O43570 3/20 0.50
▸ CA2 P00918 3/20 0.50
▸ CA4 P22748 3/20 0.50
▸ CA7 P43166 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ GAA P10253 3/20 0.50
▸ CA1 P00915 2/20 0.50
▸ CA5A P35218 2/20 0.50
▸ CA5B Q9Y2D0 2/20 0.50
▸ GLA P06280 2/20 0.50
▸ MAOB P27338 4/20 0.49
▸ MAOA P21397 1/20 0.49
▸ RAB9A P51151 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4412980 0.95 NPC1 (0.48) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL4412983 0.80 NPC1 (0.46) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL4413488 0.79 NPC1 (0.44) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL13521823 0.79 NPC1 (0.62) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL1415893 0.76 NPC1 (0.69) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL8058881 0.73 KDM4E (0.46) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL8256252 0.73 STAT3 (0.46) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL12221078 0.72 ALDH1A1 (0.61) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL10305767 0.70 NPC1 (0.77) AKR1B10AKR1B1NPC1RXFP1ALDH1A1
SCHEMBL19158900 0.70 NPC1 (0.56) AKR1B10AKR1B1NPC1RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050106100-A1 Compounds containing matrix metalloproteinase substrates and methods of their use LANTHEUS MEDICAL IMAGING, INC. 2005-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050106100-A1 Compounds containing matrix metalloproteinase substrates and methods of their use MMP1, MMP10, MMP8 AKR1B10 1872/4885AKR1B1 1636/4885NPC1 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback